1. Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study.
- Author
-
Jie Peng, Junhua Yin, Shaohang Cai, Tao Yu, and Chunxiu Zhong
- Subjects
NUCLEOSIDES ,CHRONIC hepatitis B ,SOCIODEMOGRAPHIC factors ,LAMIVUDINE ,HEPATITIS B treatment ,PATIENTS - Abstract
Little is known about the factors associated with patient compliance with nucleos(t)ide analog (NUC) treatment for chronic hepatitis B (CHB). The purpose of this study was to examine the association between sociodemographic and clinical characteristics and adherence to NUCs among patients with CHB. A total of 211 CHB patients receiving NUC monotherapy were asked to report the number of prescribed doses of medication they had taken during the last 90 days. A total of four 3-month adherence scores were averaged to obtain a combined rate of NUC adherence during a 1-year follow up period. The mean age of the patients was 29.6 years, 79% were men, and 68% had no prior NUC treatment for CHB. Females, patients without a previous NUC treatment, and those who had NUC drug resistance showed better adherence to NUC treatment, and compliance was better with telbivudine than with lamivudine and entecavir. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF